Heart attacks among adults younger than 50 years of age are on the rise. In fact, the proportion of very young people has been increasing, rising by 2 percent each year for the last 10 years, according to a team of investigators ...
May 21, 2019
0
0
LDL cholesterol – the so-called "bad" cholesterol – is known to narrow arteries, which can lead to heart attacks and strokes. It's also now suspected of contributing to venous thromboembolism, new research suggests.
May 14, 2019
0
3
A drug used in the treatment of overactive bladder can accelerate atherosclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences ...
May 14, 2019
0
44
Targeting apolipoprotein B (APOB) gene has not been tested in clinical trials for cardiovascular outcomes because of risk of fatty liver disease, but naturally-occurring mutation suggests it may be effective.
May 13, 2019
0
6
A new study shows more aggressive treatment may be needed for a large number of patients taking statin medications, and that treatment could help reduce cases of cardiovascular disease, the leading cause of death in the U.S.
May 9, 2019
0
0
Soy protein has the ability to lower cholesterol by a small but significant amount, suggests a new study led by St. Michael's Hospital in Toronto.
May 6, 2019
1
65
Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks. The findings ...
Apr 15, 2019
0
0
Lowering low-density lipoprotein (LDL) cholesterol reduces the risk of heart attacks and stroke, with an ideal value below 100 milligrams per deciliter (mg/dL). But can it be too low? A new study finds that women who have ...
Apr 10, 2019
0
2116
Low-density lipoprotein (LDL) cholesterol is a key contributor to cardiovascular disease, one of the leading causes of death globally.
Apr 10, 2019
0
6
Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or "bad" cholesterol, after 12 weeks compared to similar patients who took a placebo ...
Mar 18, 2019
0
2
